Biote (BTMD) EBIT (2021 - 2026)

Biote has reported EBIT for 6 years, with the latest figure at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 67.33% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 361.26% YoY), and the FY2025 full-year result was $7.9 million, up 3605.63% from the prior year.
• EBIT for Q1 2026 stood at $3.2 million, up from -$20.8 million in the prior quarter.
• The five-year high for EBIT was $68.4 million in Q4 2022, with the low at -$85.6 million in Q2 2022.
• Average EBIT over 5 years is $2.4 million, with a median of $7.8 million recorded in 2022.
• Peak annual rise in EBIT reached 9150.29% in 2022, while the deepest fall reached 934.34% in 2022.
• Tracing BTMD's EBIT over 5 years: stood at $68.4 million in 2022, then sank by 91.95% to $5.5 million in 2023, then sank by 619.81% to -$28.6 million in 2024, then grew by 27.25% to -$20.8 million in 2025, then jumped by 115.2% to $3.2 million in 2026.
• The last three EBIT figures came in at $3.2 million (Q1 2026), -$20.8 million (Q4 2025), and $8.3 million (Q3 2025), per Business Quant data.

Peer Comparison